PLRX PLIANT THERAPEUTICS, INC.
Price Chart
Executive Summary
Pliant Therapeutics' $300 million shelf registration, including a $50 million at-the-market (ATM) offering program, has become effective. The company can now sell securities from time to time over the next three years, creating potential for future dilution.
Actionable Insight
Monitor for future prospectus supplements or 8-K filings indicating an actual drawdown under the shelf or ATM program, which could lead to near-term stock dilution. The $81M market cap makes even modest issuances potentially impactful.
Key Facts
- Shelf registration (Form S-3) has become effective, allowing Pliant Therapeutics to raise up to $300 million in capital over the next three years.
- Of the $300 million, $50 million is designated for an at-the-market (ATM) offering program with Leerink Partners LLC.
- Securities offered may include common stock, preferred stock, debt, units, and warrants, with specific terms disclosed in future prospectus supplements.
- The effectiveness allows the company to access capital markets opportunistically, but no immediate offering has been announced.
Financial Impact
Up to $300,000,000 in potential future dilution, with $50,000,000 available immediately under the ATM program
Risk Factors
- Future equity issuances could dilute existing shareholders
- ATM program may be used during periods of low stock price, exacerbating downside pressure
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001103 |
| Document: 9999999995-26-001103-index.html | 9999999995-26-001103 |
| Document: 9999999995-26-001103.txt | 9999999995-26-001103 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 11, 2026
29d ago
|
8-K
| $1.18 $1.18 | · 0.00% | ▼ −0.08% | $1.15 (−2.54%) |
|
May 11, 2026
29d ago
|
Press Release
| $1.18 $1.18 | · 0.00% | ▲ +0.08% | $1.15 (+2.54%) |
|
Apr 17, 2026
7w ago
|
8-K
| $1.29 $1.21 | ▼ −6.20% | ▼ −7.11% | $1.15 (−10.85%) |
|
Apr 7, 2026
9w ago
|
EFFECT
| $1.31 $1.30 | ▼ −0.76% | ▼ −6.09% | $1.15 (−12.21%) |
|
Mar 11, 2026
12w ago
|
8-K
| $1.41 $1.33 | ▼ −5.67% | ▼ −4.70% | $1.15 (−18.44%) |
|
Mar 3, 2026
14w ago
|
8-K
| $1.29 $1.33 | ▲ +3.10% | ▲ +4.43% | $1.15 (−10.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access